October 17, 2018

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
17
Oct
FDA's Drug Centers Release New Draft Guidance on Quantitative Info in Consumer-Directed Ads Mintz
17
Oct
Trump Administration Proposes Requiring Disclosure of Drug Prices in TV Ads Mintz
17
Oct
EPA Proposes SNURs that Break New Ground under Amended TSCA Bergeson & Campbell, P.C.
17
Oct
FDA Sued for Failure to Implement “High-Risk” FSMA Provisions by the Statutory Deadlines Keller and Heckman LLP
16
Oct
Major Drug Company Settles Deceptive Co-Pay Coupon Class in New York Clifford Law Offices
16
Oct
New Draft Guidance on Adaptive Designs for Clinical Trials Epstein Becker & Green, P.C.
16
Oct
New OSHA Guidance: Certain Safety Incentive Programs, Post-Accident Drug Tests Permissible Jackson Lewis P.C.
16
Oct
Washington and Oregon to Vote on Soda and Food Tax Bans Keller and Heckman LLP
15
Oct
“Clarification” of Border Crossing Rules Raises More Questions for Canadian Cannabis Industry Wilson Elser Moskowitz Edelman & Dicker LLP
15
Oct
ML Strategies Health Care Preview Week of October 15 Mintz
15
Oct
Survey Assessing Level of Consumer Confusion Over Whether Plant-Based Products and Dairy Products Contain Cow’s Milk Keller and Heckman LLP
13
Oct
EU-OSHA Posts Info Sheet on Manufactured Nanomaterials in the Workplace Bergeson & Campbell, P.C.
12
Oct
Police Officer’s Disclosure of Adderall Prescription Insufficient to Support Disability Discrimination Claim Jackson Lewis P.C.
12
Oct
TTB Publishes Updated Guidelines for Formula Approvals for Domestic Producers and Importers McDermott Will & Emery
12
Oct
What “Bio-based” Means Across The Globe Bergeson & Campbell, P.C.
12
Oct
Germany Publishes Study on Health Effects of Ultrafine Particles Bergeson & Campbell, P.C.
11
Oct
FDA Issues Draft Guidance on Expanding Special 510(K) Program Barnes & Thornburg LLP
11
Oct
USDA Secretary Signals USDA Role Over Animal Cell Culture Technology Regulation Ahead of Joint USDA-FDA Meeting Keller and Heckman LLP
11
Oct
What You Need to Know About the Strengthening the Tenth Amendment Through Entrusting States (STATES) Act Stark & Stark
11
Oct
Expanded Medical Marijuana Research Bill Approved by Congress Stark & Stark

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS